Sales rise 53.99% to Rs 119.40 crore
Net profit of Fredun Pharmaceuticals rose 63.92% to Rs 6.77 crore in the quarter ended June 2025 as against Rs 4.13 crore during the previous quarter ended June 2024. Sales rose 53.99% to Rs 119.40 crore in the quarter ended June 2025 as against Rs 77.54 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 119.40 | 77.54 | 54 |
OPM % | 14.23 | 13.52 | - |
PBDT | 10.46 | 6.57 | 59 |
PBT | 9.04 | 5.52 | 64 |
NP | 6.77 | 4.13 | 64 |
Powered by Capital Market - Live News